Developmental dysplasia of the hip (DDH) is a musculoskeletal issue in newborns. DDH changes hip biomechanics, over-burdening the articular cartilage and prompting early osteoarthritis. DDH is the primary cause of total hip arthroplasty in the young age population. The major objective of treating developmental DDH is to get a concentric joint surface as expected and keep up this early treatment to accomplish normal development of the proximal femur and hip bone socket. Splint and brace are applied in various cases and are considered the gold standard for DDH with a reducible hip because while they are worn, abduction and flexing of the hips are still possible.
Literature mentions that there are many pros and cons in the use of Pavlik Harness in infants aged less than six months. Most said it was effective, some said they still needed further surgery, and some chose to wait/observe until the age of six months. The Pavlik technique has been found to have success rates as high as 98% for hip subluxation and dislocation. However, there is still discussion regarding the range of treatment, weaning management, and duration of radiographic follow-up as it identifies with requirements for reinterpretation
Pavlik Harness (dynamic splint) can be given to DDH children before the age of 6 months, but it needs periodic evaluation to prevent overtreatment or unwanted complications.
Key words: Developmental dysplasia of the hip, Pavlik Harness, Treatment
|
